MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Kristin Myers, Chief Digital Officer at Northwell Health
The MedCity Moves Podcast is back with another episode — its first of the year. During the episode, Senior Reporter ...
Saturday, January 18, 2025
Tag: stj
Top 7 Healthcare Focus Areas for Mastering Modern CPQ Technology
In an era where the precision and timeliness of healthcare delivery are paramount, digital transformation is not a business want, ...
Mitotic Counting Reimagined: When AI Meets the Microscope
Mitotic counting, or the assessment of figures indicative of cellular division, is fundamental to the pathological examination of breast cancer ...
AWS to Infuse Another $20M Into Its Health Equity Program
On Thursday, Amazon Web Services (AWS) announced plans to funnel an additional $20 million into its health equity initiativebringing the ...
Technology as a Cure: Alleviating Clinician Burnout, Empowering Pharmacists to Fill Care Gaps This Cold and Flu Season
Burnout is defined as a reduction of a fuel or substance to nothing through use or combustion. Our clinicians – ...
Breaking the Cycle: Telehealth Treatment for People in Custody is Key to Recidivism Disruption
It’s no secret that opioids have reshaped the landscape of our nation: Our healthcare system, our policymakers, and our criminal ...
Embracing the Inevitability of Aging With a Health System That Supports Doing So Gracefully
As the United States experiences demographic shifts, accelerated aging is becoming a notable trend with profound implications for various sectors, ...
How Can AI Support Value-Based Care?
Artificial Intelligence has the potential to greatly improve clinical care and support the transition to value-based care, but also comes ...
CMS Finalizes Rule Streamlining Prior Authorization Process
The Centers for Medicare and Medicaid Services finalized the CMS Interoperability and Prior Authorization Rule on Wednesday. CMS said the ...
Genetic Medicines Biotech Dyne Pulls In $345M for Clinical Tests of Muscle Drugs
Dyne Therapeutics started the new year with proof-of-concept clinical data for experimental genetic medicines addressing two rare muscle diseases—one of ...